NCT04908111 2026-04-06A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1Cancer Research UKPhase 1/2 Suspended15 enrolled
NCT02223052 2020-05-12Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic MalignanciesCelgenePhase 1 Completed89 enrolled
NCT03083743 2017-03-20A Phase III Trial of Recombinant Human Apo-2 Ligand for InjectionShanghai Gebaide Biotechnology Co., Ltd.Phase 3 Unknown417 enrolled